Skip to main content

HyTan Side Effects

Generic name: chlorpheniramine / hydrocodone

Medically reviewed by Drugs.com. Last updated on Jul 8, 2023.

Note: This document contains side effect information about chlorpheniramine / hydrocodone. Some dosage forms listed on this page may not apply to the brand name HyTan.

For Healthcare Professionals

Applies to chlorpheniramine / hydrocodone: oral capsule extended release, oral liquid, oral suspension extended release.

General

The more commonly reported adverse effects have included, sedation, somnolence, mental clouding, dizziness, nausea and vomiting.[Ref]

Respiratory

Frequency not reported: Dose-related respiratory depression including fatal respiratory depression, dryness of the pharynx, dryness of respiratory passages, laryngismus, wheezing, breathing trouble[Ref]

Nervous system

Frequency not reported: Sedation, somnolence, drowsiness, lethargy, mental and physical impairment, dizziness, headache, facial dyskinesia, feeling faint, lightheadedness, tremor[Ref]

Psychiatric

Frequency not reported: Mental clouding, confusion, anxiety, fear, dysphoria, psychic dependence, mood changes, euphoria, agitation, irritability

Gastrointestinal

Frequency not reported: Nausea, vomiting, constipation, abdominal pain, acute pancreatitis, dry mouth, dyspepsia, epigastric distress, loss of appetite[Ref]

Cardiovascular

Frequency not reported: Chest tightness

Dermatologic

Frequency not reported: Skin rash, pruritus, erythema, urticaria, excessive perspiration[Ref]

Genitourinary

Frequency not reported: Ureteral spasm, spasm of vesicle sphincters, urinary retention, dysuria, urinary frequency, urinary hesitancy[Ref]

Ocular

Frequency not reported: Blurred, double, or other visual disturbances

References

1. Product Information. Tussionex PennKinetic (chlorpheniramine-hydrocodone). UCB Pharma Inc. 2006.

2. Product Information. HyTan (chlorpheniramine-hydrocodone). Prasco Laboratories. 2006.

3. Product Information. Vituz (chlorpheniramine-hydrocodone). Hawthorn Pharmaceuticals. 2017.

4. Product Information. TussiCaps (chlorpheniramine-hydrocodone). ECR Pharmaceuticals. 2017.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.